Revmedx wins $11.42M APFIT grant for XSTAT P15
What's the deal? The XSTAT P15 applicator, a hemorrhage control device for narrow-entrance wounds, won funding on July 14, 2026 through the Pentagon's Accelerate the Procurement and Fielding of Innovative Technologies (APFIT) programDealroom has a profile for this one. Try Dealroom →. The FDA-cleared device was developed by the Naval Medical Research Command (NMRC)Dealroom has a profile for this one. Try Dealroom → with RevMedXDealroom has a profile for this one. Try Dealroom → to cut casualties in combat and deployed settings.
How it works: The XSTAT P15 inserts a pouch of miniature sponges into wounds caused by gunshots or shrapnel. The sponges expand within seconds to absorb blood and apply constant pressure without manual compression. A mesh bag holds the sponges so they can be removed easily during surgery.
Why now? Hemorrhaging causes roughly 20% of combat deaths. Service members can use the applicator without extra training, making it a portable, accessible tool that reduces the load on those in the field.
What's the endgame? The APFIT award targets a familiar bottleneck: manufacturing capacity. "Our partners in industry can output a limited number of units of a device like the XSTAT, in their current capacity," said Lt. Cmdr. John Casachahua, a product manager for NMRC Naval Advanced Medical Development (NAMD)Dealroom has a profile for this one. Try Dealroom →. "Yet through the APFIT program, NMRC was able to secure the funding to produce at scale, to meet the needs of the services."
APFIT is a competitive Department of WarDealroom has a profile for this one. Try Dealroom → program that funds small, US-based vendors to move finished products into the hands of service members. It exists to close the gap between a ready technology and its operational deployment.
Thomas Dunn, acting program manager for NAMD, called the award "a major milestone in our ongoing mission to deliver next-generation life-saving capabilities to the fleet and field." He added that the program "accelerates our ability to transition this vital technology directly into the hands of our corpsmen and medics."
The signal: The funding shows the Pentagon leaning on small, domestic vendors to convert cleared medical technology into fielded equipment. For startups in defence medtech, APFIT is a route past the manufacturing gap that often stalls promising devices before they reach users.
Image credit: U.S. Army ROTC
Read more: Design & Development Today
